1. Home
  2. GNW vs IDYA Comparison

GNW vs IDYA Comparison

Compare GNW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genworth Financial Inc

GNW

Genworth Financial Inc

HOLD

Current Price

$8.75

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.64

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNW
IDYA
Founded
1871
2015
Country
US
US
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.9B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
GNW
IDYA
Price
$8.75
$32.64
Analyst Decision
Buy
Strong Buy
Analyst Count
1
15
Target Price
$10.00
$50.15
AVG Volume (30 Days)
3.2M
762.3K
Earning Date
05-02-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
325.00
61.90
EPS
0.53
N/A
Revenue
$7,295,000,000.00
$218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$97.58
P/E Ratio
$16.73
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$5.99
$13.45
52 Week High
$9.28
$39.28

Technical Indicators

Market Signals
Indicator
GNW
IDYA
Relative Strength Index (RSI) 50.14 48.21
Support Level $8.84 $29.47
Resistance Level $9.08 $33.63
Average True Range (ATR) 0.23 1.65
MACD 0.02 -0.10
Stochastic Oscillator 56.32 62.44

Price Performance

Historical Comparison
GNW
IDYA

About GNW Genworth Financial Inc

Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: